Global Epigenetics Market 2014-2018

  • November 2013
  • -
  • Infiniti Research Limited
  • -
  • 43 pages

TechNavio forecasts The Global Epigenetics Market 2014-2018 with a CAGR of 28.79 percent for the period 2013–2018. Several driving factors and trends will contribute to this growth—all of which will be outlined with detail in this report.

TechNavio’s analysts use a unique methodology to scrutinize individual vendor performance, trends, drivers and challenges, and a number of other factors to provide the most accurate and detailed market research reports possible.

A more specific breakdown of this report’s contents is below.

Overview of market share and landscape for the following key countries:

• Americas
• EMEA
• APAC

Overview and impact analysis of:

• 3 Market Drivers
• 3 Market Challenges
• 3 Market Trends

Market Shares and SWOT Analysis for these vendors:
• Celgene Corp.
• Eisai Inc.
• Merck & Co.
Five Force Model Impact Analysis of:

• Suppliers
• Buyers
• Substitutes
• New entrants
• Market competition

Note: All of the segments above are supplemented with a combination of statistical data, graphical analysis, and verbal explanation.

After purchasing any of our reports, you can request a one hour meeting to discuss any questions you may have with our team of analysts.






Methodology

Research methodology is based on extensive primary and secondary research. Primary research includes in-depth interviews with industry experts, vendors, resellers and customers. Secondary research includes Technavio Platform, industry publications, company reports, news articles, analyst reports, trade associations and the data published by Government agencies.

Table Of Contents

Global Epigenetics Market 2014-2018
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
03.3 Product Profile
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Market Segmentation by Mechanism of Action
08. Geographical Segmentation
09. Buying Criteria
10. Market Growth Drivers
11. Drivers and their Impact
12. Market Challenges
13. Impact of Drivers and Challenges
14. Market Trends
15. Trends and their Impact
16. Vendor Landscape
16.1 Competitive Scenario
16.1.1 Key News
16.1.2 Mergers and Acquisitions
16.2 Market Share Analysis 2013
17. Key Vendor Analysis
17.1 Celgene Corp.
17.1.1 Business Overview
17.1.2 Key Information
17.1.3 SWOT Analysis
17.2 Eisai Inc.
17.2.1 Business Overview
17.2.2 Key Information
17.2.3 SWOT Analysis
17.3 Merck and Co. Inc.
17.3.1 Business Overview
17.3.2 Business Segmentation
17.3.3 Key Information
17.3.4 SWOT Analysis
18. Other Reports in this Series

List of Exhibits

Exhibit 1: Market Research Methodology
Exhibit 2: Global Epigenetics Market 2013-2018 (US$ million)
Exhibit 3: Global Epigenetics Market Segmentation by Mechanism of Action
Exhibit 4: Business Segmentation of Merck and Co., Inc.





Companies Mentioned

Celgene Corp., Eisai Inc., and Merck and Co.

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

Global Markets for Drug-Device Combinations

Global Markets for Drug-Device Combinations

  • $ 6 650
  • Industry report
  • January 2015
  • by BCC Research

REPORT HIGHLIGHTS The sales of drug-device combination products reached $21.4 billion in 2013 and $22 billion in 2014. This market is expected to grow to $31 billion in 2019, with a compound annual growth ...

A Product and Pipeline Analysis of the Antibacterial Drugs Market : Regulatory Approaches to Combat Microbial Resistance and Stimulate Antibiotics R&D

A Product and Pipeline Analysis of the Antibacterial Drugs Market : Regulatory Approaches to Combat Microbial Resistance and Stimulate Antibiotics R&D

  • $ 5 000
  • Industry report
  • January 2015
  • by Frost & Sullivan

Key Findings •2014 has turned out to be a flagship year in the history of antibacterial drugs development. oThree new systemic antibacterial drugs gained Food and Drugs Administration (FDA) approval ...

Type 2 Diabetes Therapeutics in Asia-Pacific Markets to 2020 - Increasing Uptake of Novel Drug Classes to Drive Market Growth

Type 2 Diabetes Therapeutics in Asia-Pacific Markets to 2020 - Increasing Uptake of Novel Drug Classes to Drive Market Growth

  • $ 4 995
  • Industry report
  • November 2014
  • by GBI Research

Type 2 Diabetes Therapeutics in Asia-Pacific Markets to 2020 - Increasing Uptake of Novel Drug Classes to Drive Market Growth Summary GBI Research, the leading business intelligence provider, has released ...

Injectable Drug Delivery To 2022

December 2014 $ 4 850

Drug Self-administration To 2022

December 2014 $ 4 850

Blood Disease Drugs Markets In China

December 2014 $ 4 000

Hypertension Drugs Markets In China

December 2014 $ 4 000

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.